Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.12B |
| 2 |
ExxonMobil
XOM
|
+$884M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$856M |
| 4 |
American International
AIG
|
+$594M |
| 5 |
Crown Castle
CCI
|
+$542M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
Gilead Sciences
GILD
|
+$1.23B |
| 3 |
DuPont de Nemours
DD
|
+$982M |
| 4 |
General Motors
GM
|
+$683M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUNR
401
DELISTED
Qunar Cayman Islands Limited
QUNR
| $5.31M | ﹤0.01% |
+200,000
| New | +$5.41M |
|
402
CMS Energy
CMS
$22B
| $5.09M | ﹤0.01% |
+190,000
| New | +$5.11M |
|
|
MR
403
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $4.58M | ﹤0.01% |
126,000
-1,906,600
| -94% | -$74.1M |
|
404
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $3.87M | ﹤0.01% |
328,395
+3,956
| +1% | +$44.2K |
|
405
Granite Construction
GVA
$5.52B
| $3.78M | ﹤0.01% |
+107,958
| New | +$3.39M |
|
406
BlackBerry
BB
$5.14B
| $2.79M | ﹤0.01% |
375,000
| – | – |
|
407
Clean Energy Fuels
CLNE
$384M
| $1.93M | ﹤0.01% |
150,000
| – | – |
|
408
Huntsman Corp
HUN
$1.78B
| $1.69M | ﹤0.01% |
68,600
| – | – |
|
|
MARK
409
DELISTED
Remark Holdings, Inc.
MARK
| $1.67M | ﹤0.01% |
35,902
| – | – |
|
410
Walmart Inc
WMT
$923B
| $170K | ﹤0.01% |
+6,480
| New | +$167K |
|
411
Arthur J. Gallagher & Co
AJG
$65.5B
| – | – |
-4,734,389
| Closed | -$207M |
|
412
American Express
AXP
$232B
| – | – |
-400,000
| Closed | -$30.2M |
|
413
AstraZeneca
AZN
$246B
| – | – |
-1,171,000
| Closed | -$60.8M |
|
414
Blackrock
BLK
$180B
| – | – |
-400,000
| Closed | -$108M |
|
415
Capitol Federal Financial
CFFN
$1.1B
| – | – |
-1,697,000
| Closed | -$21.1M |
|
416
Cleveland-Cliffs
CLF
$6.99B
| – | – |
-275,000
| Closed | -$5.64M |
|
417
Clorox
CLX
$12.8B
| – | – |
-700,000
| Closed | -$57.2M |
|
418
Genuine Parts
GPC
$18.5B
| – | – |
-1,160,000
| Closed | -$93.8M |
|
419
Global Payments
GPN
$23.4B
| – | – |
-1,122,232
| Closed | -$28.7M |
|
420
Hyster-Yale Materials Handling
HY
$614M
| – | – |
-168,812
| Closed | -$15.1M |
|
421
Iron Mountain
IRM
$37B
| – | – |
-1,481,412
| Closed | -$37M |
|
422
Intuitive Surgical
ISRG
$142B
| – | – |
-1,350,000
| Closed | -$56.4M |
|
423
Itaú Unibanco
ITUB
$81.6B
| – | – |
-2,437,634
| Closed | -$12.5M |
|
424
Leggett & Platt
LEG
$1.29B
| – | – |
-2,755,800
| Closed | -$83.1M |
|
425
Liquidity Services
LQDT
$1.35B
| – | – |
-1,281,944
| Closed | -$43M |
|
Similar funds
Capital Research Global Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Capital Research Global Investors held 473 positions worth $270B, up 6.6% from $253B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors withdrew a net $8.14B in Q4 2013, closing 44 positions and reducing 142 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $664M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Capital Research Global Investors opened a new position in American International worth $608M.
- Capital Research Global Investors's largest Q4 2013 buy was American International: 11,917,900 shares worth $608M.
- Capital Research Global Investors added most to Amgen in Q4 2013, an estimated $1.12B increase.
- Capital Research Global Investors's biggest Q4 2013 reduction was Microsoft, cutting an estimated $2.44B.
- Capital Research Global Investors fully exited FOREST LABORATORIES INC in Q4 2013, selling an estimated $664M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $270B portfolio in Q4 2013.
- Capital Research Global Investors opened 27 new positions and closed 44 in Q4 2013.
- Capital Research Global Investors's portfolio value rose 6.6% quarter-over-quarter to $270B.
Based on Capital Research Global Investors's 13F filing for Q4 2013, filed 14 Feb 2014.